Authors
Kuznetsov S.I., Shestakov E.A., Gusarov V.G., Fateev S.A., Zhiburt E.B.
Pirogov National Medical and Surgical Center, Moscow
Abstract
We studied the structure of recipients and blood transfusions in the COVID-19 hospital and other departments of the Pirogov Center in 2020. Among the 1,141 patients of the COVID-19 hospital, 61 patients (5.3%) and among 37,136 patients in other departments, 710 (1.9%) patients received transfusions of blood components.
During the operation of the COVID-19 hospital, the Pirogov Center’s need for donor blood components was fully met.
In the COVID-19 hospital compared to other departments:
- the part of recipients of all blood components, red blood cells and plasma was higher (p<0.01);
- 4 units and 4-6 units of red blood cells were transfused more often (p <0.01), more than 11 units of red blood cells were not transfused;
- among recipients of red blood cells, the part of people over 60 years old is 42.4% higher than the same part among other patients (p<0.01);
- among plasma recipients, the part of persons under 45 years of age is significantly reduced (p<0.05).
The data on the needs of patients in the COVID-19 hospital for transfusion therapy can be used as a benchmark for the related work planning.
Keywords: blood, blood transfusion, COVID-19, red blood cells, plasma, platelets.
References
1. Shevchenko YuL, Karpov OE, Zhiburt EB. Blood transfusion: history and modernity (on the 100th anniversary of blood transfusion in Russia). Bulletin of Pirogov National Medical & Surgical Center. 2019; 14(4): 4-11. (In Russ). doi: 10.25881/BPNMSC.2020.29.78.001.
2. Kuznecov SI, Hamitov RG, Fomina VS, et al. RBC phenotype and COVID-19 infection. Spravochnik zavedujushhego KDL. 2020; 9: 16-22. (In Russ).
3. Kuznecov SI, Kudinova EV, Zhiburt EB. Blood collection during the period of COVID-19 infection. Healthcare Manager. 2020; 5: 41-44. (In Russ).
4. Kuznecov SI, Shestakov EA, Zhiburt EB. Coagulopathy in COVID-19 infection. Thrombosis, hemostasis and rheology. 2020; 4: 31-34. (In Russ). doi: 10.25555/THR.2020.4.0942.
5. Orlov AM, Popkova NG, Galimov ML, et al. Introduction of collection and transfusion of anticovid plasma in the Sverdlovsk region. Transfusiology. 2020; 21(3): 245-252. (In Russ).
6. Makedonskaya OG, Eikhler OV, Zhiburt EB. Vaccinated — a new category of anticovid plasma donors. Bulletin of Pirogov National Medical & Surgical Center. 2020; 15(3): 77-79. (In Russ). doi: 10.25881/BPNMSC.2020.95.33.014.
7. Cai X, Ren M, Chen F, et al. Blood transfusion during the COVID-19 outbreak. Blood Transfus. 2020; 18(2): 79-82. doi: 10.2450/2020.0076-20.
8. Stanworth SJ, New HV, Apelseth, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. The Lancet. Haematology. 2020; 7(10): e756-e764. doi: 10.1016/S2352-3026(20)30186-1.
9. Barriteau CM, Bochey P, Lindholm PF, et al. Blood transfusion utilization in hospitalized COVID-19 patients. Transfusion. 2020; 60(9): 1919-1923. doi: 10.1111/trf.15947.
10. DeSimone RA, Costa VA, Kane K, et al. Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve. Transfusion. 2021; 61(3): 692-698. doi: 10.1111/trf.16202.
11. Zhiburt EB, Madzaev SR, Chemodanov IG. Complications of blood donation and blood transfusion. Moscow: Pirogov National Medical Surgical Center; 2019. (In Russ).
12. Zhiburt EB, Chemodanov IG, Averyanov EG, Kozhemyako OV. Stability of blood services. Bulletin of the National Research Institute of Public Health named after N.A. Semashko. 2017; 7: 17-24. (In Russ).
13. Zhiburt EB, Chemodanov IG, Averyanov EG, Kozhemyako OV. Benchmarking of blood transfusion in the regions of the Russian Federation. Healthcare Manager. 2017; 10: 60-64. (In Russ).
14. Gubanova MN, Serba IK, Shestakov EA et al. Evolution of blood transfusion in the Pirogov Center. Bulletin of Pirogov National Medical & Surgical Center. 2017; 12(4/2): 90-92. (In Russ).
